Skip to Content

Vadova Approval Status

FDA Approved: No
Brand name: Vadova
Generic name: carbidopa and levodopa
Dosage form: Extended Release Tablets
Company: IMPAX Laboratories, Inc.
Treatment for: Parkinson's Disease

Vadova is an extended release formulation of carbidopa and levodopa under review for the treatment of Parkinson's disease. The FDA issued a non-approvable letter for Vadova in January 2008.

Development Status and FDA Approval Process for Vadova

DateArticle
Jan 30, 2008IMPAX Receives FDA Non-Approvable Letter for Vadova; CompanyConsidering Options
Jan 18, 2007IMPAX Files Amendment to Vadova NDA

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide